USANA Health Sciences, Inc. (USNA)
Pre-market:
| Previous close | 44.13 |
| Open | 44.35 |
| Bid | 43.30 x 1000 |
| Ask | 70.76 x 1000 |
| Day's range | 44.00 - 44.62 |
| 52-week range | 42.59 - 69.60 |
| Volume | |
| Avg. volume | 84,617 |
| Market cap | 851.007M |
| Beta (5Y monthly) | 0.91 |
| PE ratio (TTM) | 13.40 |
| EPS (TTM) | 3.30 |
| Earnings date | 30 Apr 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 56.50 |
Business WireUSANA Schedules First Quarter 2024 Earnings Release and Conference Call
SALT LAKE CITY, April 10, 2024--USANA Health Sciences, Inc. (NYSE:USNA) today announced that first quarter 2024 results will be released after the close of market on Tuesday, April 30, 2024. Shortly following the issuance of the Company’s earnings release, the Company will post its Management Commentary document on the Company’s Investor Relations website (http://ir.usana.com) under the News/Events section. USANA will hold a conference call to discuss this announcement with analysts and institut
PR NewswireUSANA Cements Itself as a Premier Cellular Nutrition Company in South Korea
USANA Health Sciences, a global cellular nutrition company, was recently recognized at the prestigious Korea Medical Healthcare Awards in the multivitamin category for the sixth consecutive year and the weight management category for the fourth consecutive year.
Simply Wall St.USANA Health Sciences, Inc. (NYSE:USNA) has caught the attention of institutional investors who hold a sizeable 49% stake
Key Insights Given the large stake in the stock by institutions, USANA Health Sciences' stock price might be vulnerable...
